Back
ESC2025 Premium Access

Welcome and introductions

logo

Session: A new chapter in transthyretin amyloid cardiomyopathy (ATTR-CM): what comes next in clinical practice?
Topic: Cardiac Amyloidosis
Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)
Sponsored by Alnylam Pharmaceuticals
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)
81 presentations
20 followers

4 more presentations in this session

Evolving patient profiles in ATTR-CM: Are we ready to rethink management?

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Access
Like
Thumbnail

At the heart of ATTR-CM: Redefining first-line therapy in contemporary care

Speaker: Professor M. Fontana (London, GB)

Access
Like
Thumbnail

From evidence to action: translating data into clinical practice

Speaker: Doctor N. Sarswat (Chicago, US)

Access
Like
Thumbnail

Panel discussion and audience Q&A

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES) Professor M. Fontana (London, GB) Doctor N. Sarswat (Chicago, US)

Access
Like
Thumbnail

Access the full session

A new chapter in transthyretin amyloid cardiomyopathy (ATTR-CM): what comes next in clinical practice?

Speakers: Doctor P. Garcia-Pavia, Doctor P. Garcia-Pavia, Professor M. Fontana, Doctor N. Sarswat, Doctor P. Garcia-Pavia...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources